Although the Supreme Court has recently increased its review of patent laws, the rulings have only eliminated deviations and reinforced precedent. However, the implications for nutraceutical companies is that their patent applications would have to represent a true invention and be very precise, rather than being a collection of scientific facts or trivial improvements. In his byline on www.nutraingredients-usa.com, Foley’s John Garvey discusses three recent cases reviewed by the Supreme Court and the impact of these decisions on dietary supplement and functional foods companies looking to patent their technologies.
Related Insights
December 5, 2025
Labor & Employment Law Perspectives
Ninth Circuit Ruling Upholds Employee Speech Amid Stalled NLRB
Like it or not, social media has become the backdrop of almost everything we do. It's how many people read the news, interact with…
December 5, 2025
Legal News: International Trade Enforcement & Compliance
What Every Multinational Should Know About … Preserving the Right to IEEPA Tariff Refunds
Any company that has imported goods subject to the Trump administration’s fentanyl-based tariffs or reciprocal tariffs — i.e., the tariffs levied pursuant to the International Emergency Economic Powers Act (the IEEPA tariffs) — needs to consider filing an action in the U.S. Court of International Trade (CIT) to preserve the possibility of recovering refunds of these tariffs.
December 4, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…